Telomere shortening in arteries could lead to telomere uncapping and cellular senescence, which in turn could promote the development of hypertension.
To assess the novel role of arterial telomere dysfunction in hypertension, we compared mean telomere length (qPCR), telomere uncapping (serine 139 phosphorylated histone γ-H2A.X (γ-H2) localized to telomeres: ChIP), and tumor suppressor protein p53 (P53)/cyclin-dependent kinase inhibitor 1A (P21)-induced senescence (P53 bound to P21 gene promoter: ChIP) in arteries from 55 age-matched hypertensive and nonhypertensive individuals. Arterial mean telomere length was not different in hypertensive patients compared with nonhypertensive individuals (P = 0.29). Arterial telomere uncapping and P53/P21-induced senescence were two-fold greater in hypertensive patients compared with nonhypertensive individuals (P = 0.04 and P = 0.02, respectively). Arterial mean telomere length was not associated with telomere uncapping or P53/P21-induced senescence (r = −0.02, P = 0.44 and r = 0.01, P = 0.50, respectively), but telomere uncapping was a highly influential covariate for the hypertension group difference in P53/P21-induced senescence (r = 0.62, P < 0.001, η p 2 = 0.35). Finally, telomere uncapping was a significant predictor of hypertension status (P = 0.03), whereas mean telomere length was not (P = 0.68).
Collectively, these findings demonstrate that arterial telomere uncapping and P53/P21-induced senescence are linked to hypertension independently of mean telomere length, and telomere uncapping influences hypertension status more than mean telomere length.
Supplemental Digital Content is available in the text
aGeorge E. Wahlen Department of Veterans Affairs Medical Center
bGeriatric Research Education and Clinical Center, Salt Lake City Geriatrics Research, Education, and Clinical Center (182), Veterans Administration Salt Lake City Health Care System
cDivision of Geriatrics, Department of Internal Medicine, University of Utah School of Medicine
dDepartment of Human Genetics, Eccles Institute of Human Genetics
eDepartment of Surgery, University of Utah Health Sciences Center
fDepartment of Exercise and Sports Science, College of Health, University of Utah, Salt Lake City, Utah, USA
Correspondence to Anthony Donato, PhD, Division of Geriatrics, Department of Internal Medicine, University of Utah Veteran's Affairs Medical Center-SLC, GRECC Building 2, Rm 1D28, 500 Foothill Drive, Salt Lake City, UT 84148, USA. Tel: +1 801 582 1565x4331; fax: +1 801 585 3884; e-mail: firstname.lastname@example.org
Abbreviations: COPD, chronic obstructive pulmonary disease; CVDs, cardiovascular diseases; LDH, lactate dehydrogenase; LSD, least significance difference; P21, cyclin-dependent kinase inhibitor 1A; P53, tumor suppressor protein p53; pseudo R 2, Nagelkerke's R 2; r, Pearson correlation coefficient; S, single copy gene; T, telomeric DNA; WBCs, white blood cells; γ-H2, phosphorylated histone γ-H2A.X at serine 139; η p 2, partial eta squared
Received 25 October, 2013
Revised 14 December, 2013
Accepted 30 January, 2014
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).